<DOC>
	<DOC>NCT01569906</DOC>
	<brief_summary>To assess prospectively, the response of moderate to severe atopic eczema to a standard course of narrowband ultraviolet B phototherapy by using validated objective and subjective scoring systems.</brief_summary>
	<brief_title>Narrowband UVB for Children With Moderate to Severe Atopic Eczema</brief_title>
	<detailed_description>Children with moderate to severe atopic eczema prescribed a course of narrowband UVB phototherapy were scored (using validated scoring systems) objectively and subjectively before, during and after the course of treatment, as well as 3 and 6 months post treatment (to determine length of remission). Their scores were compared to a control group. The control group comprised children with moderate to severe atopic eczema who were offered UVB but were unable to undertake the treatment.</detailed_description>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Dermatitis, Atopic</mesh_term>
	<criteria>Children aged 316 years with moderate to severe atopic eczema (as defined by the modified Hannifin and Rajka criteria) in whom there is a clinical indication for phototherapy (as deemed by their specialist Dermatology consultant). Children under the age of 3 years or any child who lacks the maturity needed to stand in the phototherapy cabinet unsupervised. Mild disease (defined as a Six Area Six Sign Atopic Dermatitis (SASSAD) score &lt;10)</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Atopic Dermatitis</keyword>
</DOC>